Stay updated on NAC vs Ambroxol vs Placebo in Respiratory Patients Clinical Trial
Sign up to get notified when there's something new on the NAC vs Ambroxol vs Placebo in Respiratory Patients Clinical Trial page.

Latest updates to the NAC vs Ambroxol vs Placebo in Respiratory Patients Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe study's Locations section now includes No. 299, Qing Yang Rd., Wuxi City, Jiangsu, and the previous location entry along with the HHS Vulnerability Disclosure link were removed (Revision: v3.3.3).SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange Detected- Revision updated from v3.2.0 to v3.3.2.SummaryDifference0.0%

- Check48 days agoChange DetectedThe government funding/operating status notice was removed from the page, including guidance about potential delays and status updates.SummaryDifference0.3%

- Check62 days agoChange DetectedNo additions or deletions were detected on the Study Details page for NCT03843541; the content and structure appear unchanged.SummaryDifference0.3%

- Check91 days agoChange DetectedCore content updated with a government-operating-status notice and a version upgrade to v3.2.0, replacing the previous v3.1.0.SummaryDifference3%

- Check98 days agoChange DetectedVersion bump to v3.1.0 accompanies removal of several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs), suggesting a reorganization or narrowing of content rather than new substantive material.SummaryDifference0.3%

Stay in the know with updates to NAC vs Ambroxol vs Placebo in Respiratory Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NAC vs Ambroxol vs Placebo in Respiratory Patients Clinical Trial page.